Cancer drug trade margin capped at 30%, prices may fall 70%
The government has capped the trade margin on all non-scheduled anti-cancer drugs at a maximum of 30 per cent, a move aimed at cutting excessive mark-ups and reducing patients' out-of-pocket expenses. The…
